Distinctive molecular features of radiation-induced thyroid cancers.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40845117.
- Also identified by DOI 10.1126/sciadv.adw7680 and PMC identifier 12372901.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Papillary thyroid carcinoma (PTC) incidence increased after childhood exposure to radioactive fallout from the Chornobyl accident. We investigated PTC genomic profiles to distinguish radiation-induced versus sporadic oncogenic drivers by modeling dose and molecular characteristics by driver category: <i>BRAF<sup>V600E</sup></i> (<i>n</i> = 132), RAS mutation (<i>n</i> = 31), fusions generated from two breakpoints and <20 base pairs (bp) breakpoint gain/loss (Fusion<sup>2B<20bp</sup>; <i>n</i> = 63), or ≥3 breakpoints and ≥1000 bp breakpoint loss (<i>n</i> = 20). The frequency of Fusion<sup>2B<20bp</sup>-PTC increased with increasing thyroid radiation dose, whereas all others declined. Clonal small deletion counts increased with increasing radiation dose for Fusion<sup>2B<20bp</sup>-PTC (<i>P</i> = 5.1 × 10<sup>-4</sup>) but not other drivers (<i>P</i> > 0.08). Clonal clock mutational signatures, marking the age of tumor initiation, were associated with age at the accident for Fusion<sup>2B<20bp</sup>-PTC (<i>P</i> = 8.2 × 10<sup>-4</sup>) but not other drivers (<i>P</i> > 0.21). Together, these results support a causal role for ionizing radiation in Fusion<sup>2B<20bp</sup>-PTC as a group but not other drivers.
Medical subject headings
- Thyroid Neoplasms
- Neoplasms, Radiation-Induced
- Thyroid Cancer, Papillary